Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...
Truist Securities adjusted its outlook on Amazon.com (NASDAQ:AMZN) shares, reducing the price target to $265 from the ...
Discover Truist’s checking account features, fees, and benefits in our comprehensive review. Learn how to maximize perks and ...
In a report released today, Neal Dingmann from Truist Financial maintained a Buy rating on Conocophillips (COP – Research Report). The ...
Truist Financial analyst Terry Tillman reiterated a Buy rating on Paylocity (PCTY – Research Report) today. The company’s shares closed ...
We recently compiled a list of the 10 Best Local Bank Stocks to Buy. In this article, we are going to take a look at where ...
Truist Financial Corporation ( NYSE:TFC ) has announced that it will pay a dividend of $0.52 per share on the 3rd ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $215.8, along ...
A year after entering the market, Pinnacle Financial Partners has hired a team of 45 people in Jacksonville and expects to ...
In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results